Three participants withdrew or were lost to follow up and two participants experienced protocol deviations
Semaglutide, a glucagon-like peptide receptor agonist (GLP- 1 RA), was shown in STEP 1 to produce mean weight reduction from baseline to week 68 of 14.9% for semaglutide versus 2.4% for placebo, by treatment-policy or treatment-regimen estimand which is reported throughout this manuscript, except where noted [1]
Common complaint themes center on cancellation friction, refund disputes after a prescription has shipped, and confusion when a marketing-page price does not match the checkout total
In a Plus, in a 2022 clinical trial, adults who stopped taking Wegovy after 68 weeks of Wegovy treatment regained two-thirds of the weight they lost within a year of stopping treatment
Wirtz MM, Hendrix P, Goren O, Beckett LA, Dicristina HR, Schirmer CM, Dalal S, Weiner G, Foreman PM, Zand R, Griessenauer CJ (2021) Predictor of 90-day functional outcome after mechanical thrombectomy for large vessel occlusion stroke: NIHSS score of 10 or less at 24 hours
As a supplement, it's often used to manage nerve pain, reduce inflammation and lower blood sugar